Every round on record, with the sources behind each and the investors on them.
A UK-headquartered European deep tech company
standardx.techLondon, UKMedtech
| Round | Amount | Announced | Lead | Verified | Status | Sources |
|---|---|---|---|---|---|---|
| Seed Seed | $13.4M £10m | 2026-09-23 | Vsquared Ventures, East X Ventures | 4 | [ PUBLISHED ] | 4 |
[ VERIFIED ]0.94 reconciled across 4 sources by gpt-5.6-luna
[ BUILT WITH ]·[ SEARCH ]found by corroboration·[ SCRAPE ]4 pages read: sifted.eu, tech.eu, techfundingnews.com·[ JSON ]round extracted with a schema, grounded to one sentence·[ VERIFY ]confirmedread back across 4 sources by gpt-5.6-luna·[ BRANDING ]logo and colour from the homepage·[ AGENT ]dossier built by the Firecrawl agent | ||||||
StandardX is building a deployable isotope refinery that uses a proprietary accelerator to produce rare materials for medicine, fusion energy, and other advanced industries.
| Round | Amount | Announced | Lead |
|---|---|---|---|
| Seed | £10m | 2026-09-23 | Vsquared Ventures, East X Ventures |
The company says isotope production is constrained by ageing, fragmented infrastructure, creating shortages that already affect cancer diagnosis and treatment and could limit future fusion energy. Its £10m seed round funds the first London refinery, pilot production for a medical partner in 2027, and a platform intended to manufacture a broad portfolio of isotopes at commercial scale.